Asthma Clinical Trials in McKinney, Texas

6 studies are recruiting for asthma in McKinney, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

    This is a dose-range finding, double-blind, placebo-controlled, phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolled asthma receiving medium-to-high dose inhaled corticosteroids.

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Research Site, McKinney, Texas
    Locations
    223 in total
    Run by
    AstraZeneca

    See if you can join NCT06932263 on ClinicalTrials.gov

  2. Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma

    This is a global Phase 2 study divided in two parts. Part A is a double-blind, randomized dose-range finding study in adults with moderate to severe asthma to confirm the dosing regimen of WIN378 that can be tested in future pivotal trials for efficacy and safety. Part B is a pivotal double-blind, …

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    WB Contracted Clinical Research Site, McKinney, Texas
    Locations
    73 in total
    Run by
    Windward Bio

    See if you can join NCT07120503 on ClinicalTrials.gov

  3. Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

    The purpose of this study is to compare the effect of budesonide/albuterol metered-dose inhaler (BDA MDI) with albuterol sulfate metered-dose inhaler (AS MDI), both administered as needed, on the annualized rate of severe asthma exacerbations in adolescents with a documented clinical diagnosis of a…

    Stage
    Phase 3
    Ages
    12 to 17
    Site
    Research Site, McKinney, Texas
    Locations
    155 in total
    Run by
    AstraZeneca

    See if you can join NCT06307665 on ClinicalTrials.gov

  4. A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

    The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of life and functioning o…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Metroplex Pulmonary and Sleep Center, McKinney, Texas
    Locations
    137 in total
    Run by
    Pfizer

    See if you can join NCT06977581 on ClinicalTrials.gov

  5. ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

    This study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and potential efficacy of ENV-294 in adults with moderate to severe asthma who are receiving background treatment with inhaled corticosteroids (ICS) and long-acting beta₂-agonists (LABA). Participants w…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Enveda Investigative Site, McKinney, Texas
    Locations
    20 in total
    Run by
    Enveda Therapeutics

    See if you can join NCT07301255 on ClinicalTrials.gov

  6. Depemokimab Asthma Imaging and Bronchoscopy Sub-Study

    Asthma is a chronic condition marked by narrowed and swollen airways due to inflammation leading to recurring symptoms that can vary and worsen unpredictably.\xa0The purpose of this study is to assess how depemokimab, a monoclonal antibody, affects the structure and function of the lungs in asthmat…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    GSK Investigational Site, McKinney, Texas
    Locations
    50 in total
    Run by
    GlaxoSmithKline

    See if you can join NCT06979323 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.